Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction.
FDA’s Peter Marks says some secondary cancer cases after CAR-T therapy may be ‘causal,’ but benefits still outweigh risks: #JPM24
The FDA believes that the benefit of CAR-T therapies continues to outweigh their risks amid an ongoing investigation on cases of second blood cancers developing